O

Option Care Health

Largest independent home infusion therapy provider

Nurse Practitioner - Moncks Corner Infusion Center

Full-Time
$97.1k - $161.9k+ 401(k) Match
Junior
Master's, PhD
Moncks Corner, SC, USA
In PersonMust travel between local infusion centers as needed for clinical coverage or training.
Medical, Clinical & VeterinaryAdvanced Practice Providers

About the job

Requirements
  • A Master's or Doctoral degree from an accredited Nurse Practitioner program.
  • An active and unrestricted Nurse Practitioner license in the practicing state.
  • Board certification as an NP (FNP, AGNP, or applicable specialty).
  • Current Basic Life Support certification.
  • At least one year of Nurse Practitioner experience in a clinical setting.
  • Prior experience with intravenous therapy or infusion services.
  • Proficiency in electronic health record systems.
  • Ability to maintain licensure and provide payer documentation for billing and reimbursement.
  • Ability to stand and perform clinical care for extended periods.
  • Ability to lift and move equipment and supplies up to 25 pounds as needed.
  • Ability to perform duties in a fast-paced environment while maintaining accuracy and patient safety.
Responsibilities
  • Provide comprehensive, hands-on patient care, including assessments, physical exams, and treatment of infusion therapy-related conditions.
  • Prescribe and manage medications related to infusion care in compliance with state regulations and collaborative practice agreements.
  • Order and interpret laboratory tests, diagnostics, and therapy-specific tests.
  • Oversee and perform intravenous, intramuscular, and subcutaneous medication administration and monitor for side effects or adverse events.
  • Create, document, and update individualized infusion care plans and maintain thorough, timely documentation in the electronic health record.
  • Conduct initial patient evaluations for therapy appropriateness, including payer criteria and clinical suitability for the infusion center setting.
  • Communicate with medical directors, referring physicians, and interdisciplinary staff regarding care coordination.
  • Identify urgent or emergent reactions during infusion, initiate appropriate interventions, and coordinate emergency transfers when necessary.
  • Provide clinical guidance to infusion nurses and support staff on patient care and clinical protocols.
  • Support patient education, counseling, and safe transitions of care across healthcare settings.
  • Participate in quality improvement initiatives and operational planning efforts across the infusion center.
  • Participate in credentialing and contracting processes by maintaining payer-required licenses and individual National Provider Identifier enrollment linked to the organization's Tax ID.
  • Perform duties in compliance with HIPAA, OSHA, ACHC, and applicable federal and state guidelines.
  • Travel between local infusion centers as needed for clinical coverage or training.
Desired Qualifications
  • Experience with biologics, specialty medications, or immunotherapy.
  • Prior telehealth or remote monitoring experience.
  • Supervisory or team leadership experience in a clinical setting.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Time Off
  • Bonding Time Off
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Health Savings Account/Flexible Spending Account
  • Flexible Spending Accounts
  • Tuition Reimbursement
  • Family Support
  • Mental Health Support

Company News

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.